OXERVATE
OXERVATE
Discontinued
DIN Number
02485613
Drug Class
Human
Market Date
Feb 18, 2022
Company
HC
Dompe Farmaceutici SpA
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02485613
AIG Number0161210002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
S01XA24 CENEGERMIN
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:08.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CENEGERMINActive
Strength: 0.002 %
Monograph: CENEGERMIN